Yahoo
Tokyo - Delayed Quote JPY

Mitsui Chemicals, Inc. (4183.T)

2,086.00 -22.50 (-1.07%)
At close: October 30 at 3:30:00 PM GMT+9
Chart Range Bar
Loading chart for 4183.T
  • Previous Close 2,108.50
  • Open 2,103.00
  • Bid 2,080.00 x --
  • Ask 2,088.00 x --
  • Day's Range 2,078.00 - 2,143.50
  • 52 Week Range 1,737.00 - 2,477.50
  • Volume 2,258,300
  • Avg. Volume 2,407,618
  • Market Cap (intraday) 754.167B
  • Beta (5Y Monthly) 0.78
  • PE Ratio (TTM) 11.70
  • EPS (TTM) 178.28
  • Earnings Date Nov 11, 2026
  • Forward Dividend & Yield 75.00 (3.60%)
  • Ex-Dividend Date Mar 30, 2027
  • 1y Target Est 2,509.09

Mitsui Chemicals, Inc. manufacture and sell goods or services in life & healthcare solutions, mobility solutions, ICT solutions, and basic & green materials worldwide. The company offers vision care materials, nonwoven fabrics and personal care materials, agrochemicals, and oral care materials; and elastomers, performance and polypropylene compounds, and other materials. It also provides semiconductor solutions, such as electronic component processing materials, optical materials, and lithium-ion battery materials; food packaging materials; imaging solutions, such as lens materials, materials for reflective films, and LCD and OLED sealing materials; battery material solutions; and converting solutions, including heat sealants, barrier coating materials, and packaging adhesives. In addition, the company offers petrochemicals, which comprise ethylene, propylene, high- and low-density polyethylene; basic chemicals, such as phenol, bisphenol, acetone, isopropyl alcohol, methyl isobutyl ketone, purified terephthalic acid, PET resin, ethylene oxide and glycol, hydroquinone, meta/para-cresol, ammonia, urea, and melamine; and polyurethane raw materials. Further, it provides life care solutions, such as ophthalmic lens materials, photochromic lens materials, coating materials, nonwovens, shape holding, breathable films, filtration devise, acrylamide, methacrylamide, and synthetic pulp; agrochemical products, including insecticides, fungicides, herbicides, non-crop specialty chemicals, pet medication ingredients; and medical solutions, restoratives, adhesives, artificial teeth, denture materials, impression, digital equipment/materials, medical materials, genetic testing, and contract genetic analysis services. It sells its products in Japan, China, Asia, the Americas, Europe, and internationally. Mitsui Chemicals, Inc. was founded in 1892 and is headquartered in Tokyo, Japan.

jp.mitsuichemicals.com/en

16,967

Full Time Employees

March 31

Fiscal Year Ends

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .

YTD Return

4183.T
8.17%
Nikkei 225 (^N225)
25.73%

1-Year Return

4183.T
18.02%
Nikkei 225 (^N225)
23.31%

3-Year Return

4183.T
25.57%
Nikkei 225 (^N225)
106.18%

5-Year Return

4183.T
49.30%
Nikkei 225 (^N225)
119.05%

Earnings Trends

View More

Earnings Per Share (GAAP)

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY27
Revenue 460.05B
Earnings 32.09B
Profit Margin 6.98%

Q2

FY26

Q3

FY26

Q4

FY26

Q1

FY27

0
100B
200B
300B
400B
2.0%
3.0%
4.0%
5.0%
6.0%

Analyst Insights

View More

Analyst Price Targets

1,880.00
2,509.09 Average
2,086.00 Current
3,600.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    3.84%

  • Return on Assets (ttm)

    3.24%

  • Return on Equity (ttm)

    8.04%

  • Revenue (ttm)

    1.71T

  • Net Income Avi to Common (ttm)

    65.74B

  • Diluted EPS (ttm)

    178.28

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    217.84B

  • Total Debt/Equity (mrq)

    82.39%

  • Levered Free Cash Flow (ttm)

    -5.86B

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: